Australia approves swine flu vaccine; trials in pregnant women in US
This article was originally published in SRA
Executive Summary
Pharmaceutical companies around the world are making progress in tackling the 2009 H1N1 influenza (swine flu) virus. Australia’s Therapeutic Goods Administration is the latest regulatory authority to grant approval to an H1N1 vaccine1,2. Approval was granted using the so-called progressive assessment process, whereby the TGA analysed data on a rolling basis as they became available.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.